Every article on this site is written by AI from official sources and checked by a second AI. How it works
Proposed rule

Schedules of Controlled Substances: Placement of Diphenidine in Schedule I

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register May 26, 2026. Document 2026-10380. Updated Nov. 10, 2026.

What it does

The Drug Enforcement Administration proposes placing diphenidine (1-(1,2-diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle diphenidine.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What it would change

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1308

What happens next and when

Comments must be submitted electronically or postmarked on or before June 25, 2026. The electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period.

The agency's dates, word for word.

Document number2026-10380
ActionNotice of proposed rulemaking.
AgenciesJustice Department; Drug Enforcement Administration
PublishedMay 26, 2026
Comments closeJune 25, 2026
DocketDEA-2026-0892

Source: the Federal Register (public domain). The document in the Federal Register